Recombinant CD40-ligand Uses, Dosage, Side Effects and more
Recombinant CD40-ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
| Trade Name | Recombinant CD40-ligand |
| Generic | Recombinant CD40-ligand |
| Recombinant CD40-ligand Other Names | CD40 ligand, Recombinant CD40-ligand |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
